Nanobiotix Names Laurent Condomine To Its Non-Executive Board
Nanobiotix, a Paris-based nanomedecine company that is developing cancer treatments, named Laurent Condomine to its non-executive board. Condomine has been vice president of business development at AstraZeneca. Nanobiotix has been primarily funded by European venture capital firms: Amorcage Rhone-Alpes, Cap Decisif, CIC Vizille, Masseran Gestion-CGE, Matignon Technologies and OTC Asset Management.
7 September 2010•3 mins read
